Revenue Recognition and Accounts Receivable - Schedule of Net Sales by Major Product Category by Reporting Segment (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 188,608	$ 175,204
Change	7.70%
Bone Growth Therapies [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 52,477	47,714
Change	10.00%
Spinal Implants, Biologics, and Enabling Technologies [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 108,816	101,492
Change	7.20%
Global Spine [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 161,293	149,206
Change	8.10%
Global Orthopedics [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 27,315	$ 25,998
Change	5.10%